Popular filter options for sbrt trials
Adenocarcinoma Clinical Trials
View 25 Adenocarcinoma medical studies.
Radiation Therapy
Novalis Tx for Prostate Cancer
The purpose of this trial is to evaluate a short course of very focused (stereotactic) external beam radiation therapy for the treatment of early stage prostate cancer. The investigators will gather scientific information about the tolerance and side effects this type of radiation. The investigators will then compare these results with those of standard 8 week course of external beam radiation therapy to see if this study treatment is equally or more effective in treating prostate cancer.
Radiation Therapy
CyberKnife Radiosurgery for Prostate Cancer
The purpose of this study is to determine the effects of CyberKnife radiosurgery in patients with early stage prostate cancer. The investigators hypothesize that hypofractionated stereotactic radiotherapy via the CyberKnife® can deliver tumor ablating doses of radiation to prostate tumors safely and effectively while sparing the adjacent tissues (rectum, bladder, ureters, urethra, penile bulb, and bowel) from receiving damaging doses of radiation.
Radiation Therapy
CyberKnife Stereotactic Ablative Body Radiation Therapy for Prostate Cancer
The purpose of this study is to determine the side effects and how effective CyberKnife stereotactic ablative body radiation (SABR) is in patients with prostate cancer. The CyberKnife system is a new type of radiation machine that uses a special system to precisely focus large doses of x-rays on the tumor. The device is designed to concentrate large doses of radiation onto the tumor so that injury from radiation to the nearby normal tissue will be minimal. The purpose of this evaluation is to see if this treatment will help patients with low to intermediate risk prostate cancer and to evaluate the effect of this treatment on the patients' quality of life over time.
NSCLC Clinical Trials
View 19 NSCLC medical studies.
Radiation
Stereotactic Ablative Radiosurgery for Lung Cancer
This trial is for patients with early stage lung cancer or a single pulmonary metastasis. Three tumor locator beacons are placed in the small bronchial airways near the tumors. This allows for smaller treatment volumes of Stereotactic Ablative Radiosurgery (SABR) and more precise delivery of radiotherapy.
Phase 3 Sbrt Clinical Trials
View 100 phase 3 sbrt medical studies.
Radiation Therapy
Radiosurgery vs Whole Brain Radiation for Brain Metastasis
This trial compares stereotactic radiosurgery with whole brain radiation therapy to see how well they work in treating patients with non-melanoma cancer that has recently spread from the first location to the brain.
Radiation Therapy
Fixed Gantry Radiosurgery +1 More for Brain Metastasis
Radiosurgery is precisely delivered high dose radiation. It can be performed using multiple cobalt sources, a modified traditional gantry-based linear accelerator or a robotic linear accelerator. The treatment of brain metastases represents the most common indication for radiosurgery while new indications for this technology are continually being discovered. With the increasing importance of radiosurgery and the resource implications for radiotherapy programs the investigators have proposed the first direct technological comparison of robotic to linear accelerator radiosurgery for brain metastases.
Radiation
Stereotactic Radiosurgery vs. HA-WBRT + Memantine for Brain Cancer
This trial is testing whether memantine used in combination with HA-WBRT helps to improve mental function (measured by how well patients can remember things) compared to those who receive HA-WBRT alone.
Sbrt Clinical Trials With No Placebo
View 100 sbrt medical studies that do not have a placebo group.
Radiation Therapy
Radiosurgery vs Whole Brain Radiation for Brain Metastasis
This trial compares stereotactic radiosurgery with whole brain radiation therapy to see how well they work in treating patients with non-melanoma cancer that has recently spread from the first location to the brain.
Radiation Therapy
Frameless Stereotactic Radiosurgery for Brain Tumor
The investigators plan to study high dose, single treatment radiation, using a plastic mask instead of a head frame that pins into a patient's skull. The investigators need to (1) quantify set-up accuracy and patient motion during radiation treatment and (2) ensure that without the head frame the tumour control rate and risk of complications are similar to our previous experience using the head frame.
Radiation Therapy
Fixed Gantry Radiosurgery +1 More for Brain Metastasis
Radiosurgery is precisely delivered high dose radiation. It can be performed using multiple cobalt sources, a modified traditional gantry-based linear accelerator or a robotic linear accelerator. The treatment of brain metastases represents the most common indication for radiosurgery while new indications for this technology are continually being discovered. With the increasing importance of radiosurgery and the resource implications for radiotherapy programs the investigators have proposed the first direct technological comparison of robotic to linear accelerator radiosurgery for brain metastases.
View More Sbrt Trials
See another 68 medical studies focused on sbrt.
Frequently Asked Questions
Introduction to sbrt
What are the top hospitals conducting sbrt research?
Cutting-edge advancements in the field of radiation therapy are being pioneered by top hospitals across the globe, with a particular focus on Stereotactic Body Radiation Therapy (SBRT). Hospitals such as M D Anderson Cancer Center in Houston are leading the way with six active SBRT trials. Notably, this center has embarked on groundbreaking research to enhance treatment options for patients using SBRT. In Boston, Beth Israel Deaconess Medical Center is also making significant strides, currently conducting four active SBRT trials. The collaboration between researchers and physicians at this esteemed institution aims to revolutionize cancer care through innovative approaches utilizing SBRT technology.
Venturing northward to Edmonton's Cross Cancer Institute reveals another hub of pioneering medical research. With four ongoing clinical trials centered around SBRT, this Canadian institute plays a vital role in advancing knowledge and improving outcomes for patients undergoing radiotherapy treatments. Similarly focused on innovation is Emory University Hospital/Winship Cancer Institute in Atlanta where an equal number of active SBRT trials are underway. By exploring the potential of this cutting-edge technology, these institutions aim to optimize radiation therapy protocols and ultimately improve patient survival rates.
Situated in Hamilton, Canada's Juravinski Cancer Centre completes our list of top hospitals involved in current SBRT trials. This dynamic facility is actively engaged in three clinical studies that harness the power of precise radiation delivery techniques offered by SBRT. Through their commitment to advancing scientific understanding and patient care within oncology treatments like SBRT, these hospitals contribute significantly towards better outcomes for individuals facing various forms of cancer requiring radiation intervention.
Collectively, these world-class medical institutions showcase their unwavering dedication to finding innovative solutions that challenge conventional practices while aiming for improved therapeutic success rates with minimally invasive procedures.
Which are the best cities for sbrt clinical trials?
When it comes to sbrt clinical trials, several cities stand out as hubs of research and development. New york, New York leads the way with 20 active trials exploring treatments like Fractionated Stereotactic Radiosurgery and Pembrolizumab combined with SRS. Boston, Massachusetts closely follows with 19 ongoing studies focused on interventions such as FOLFIRINOX and AGuIX. Houston, Texas is also a notable location with 14 active trials investigating treatments like Stereotactic Radiosurgery and the NovoTTF-200M device. Lastly, Montréal, Quebec offers promising opportunities with 13 active trials studying SBRT and other potential breakthroughs. These cities provide access to cutting-edge sbrt clinical trials that drive innovation in care for patients seeking advanced treatment options.
Which are the top treatments for sbrt being explored in clinical trials?
Stereotactic body radiation therapy (SBRT) is an area of active research, with several promising treatments currently being explored in clinical trials. Among the top contenders are:
- Daratumumab: Being tested in 6 ongoing SBRT trials
- Belantamab mafodotin: Under investigation in 4 active SBRT studies
- Lenalidomide: Currently involved in 3 clinical trials focused on SBRT.
What are the most recent clinical trials for sbrt?
The field of Stereotactic Body Radiation Therapy (SBRT) is witnessing promising advancements through recent clinical trials. One such study focuses on men with low to intermediate risk prostate cancer, evaluating the effectiveness of SBRT as a treatment option. Another trial investigates the application of radiosurgery in SBRT, seeking to determine its potential benefits across different phases. Additionally, cisplatin has emerged as a candidate for use alongside SBRT, offering new possibilities for patient care. Notably, standard dose SBRT and olaparib have also been explored in separate Phase 2 trials, presenting alternative avenues for optimizing treatment outcomes. These ongoing studies hold promise for refining and expanding the role of SBRT in various medical contexts.
What sbrt clinical trials were recently completed?
Recently completed clinical trials in the field of Stereotactic Body Radiation Therapy (SBRT) have made significant contributions to advancing cancer treatment. Notably, a trial investigating the efficacy and safety of SBRT for lung cancer was successfully completed, providing valuable insights into this innovative therapy. The completion of this groundbreaking study marks an important milestone in improving outcomes for patients undergoing radiation therapy for lung cancer.